Find your path to Clifford
48 people in our graph share verified history with Clifford — schools, employers, funds. One of them is your warm intro.
Clinton BybeeunlockedClifford: together at The University of Chicago Booth School of Business (1988–1989)
×5Clifford: together at The University of Chicago Booth School of Business
Clifford: together at University of Chicago Department of Molecular Genetics and Cell Biology (MGCB)
Clifford: together at Calistoga Pharmaceuticals (acquired by Gilead 2011)
Executive at OncoResponse
Intro paths
→
In turn, Clifford can intro founders to OncoResponse's investors below.
OncoResponse's investors · 10
3B Future Health FundMonaco · $12M checks · since 2025ARCH Venture PartnersChicago · $50K – $250M checks · since 2021Bering CapitalSan Francisco · since 2023Canaan PartnersStamford · $500K – $20M checks · since 2025GreatPoint VenturesSan Francisco · $250K – $20M checksIntervestChevy Chase · since 2023Qatar Investment AuthorityDohaRiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2025Takeda VenturesCambridge · $1M – $5M checks · since 2023Yonjin Venture LLCCambridge
Experience
- OncoResponseChief Executive Officercurrent2015 — presentHouston, TX
- Theraclone Sciences, Inc.Chief Executive Officer2011 — 20161124 Columbia Street; Suite 300; Seattle, WA 98104
- Calistoga Pharmaceuticals (acquired by Gilead 2011)Chief Business Officer2009 — 2011
- MarketGain PartnersManaging Director2007 — 2009
- ICOS Corporation (acquired by Lilly for $2.3 Billion in 2007)Vice President, Business Development1992 — 2007
- Booz Allen & HamiltonManagement Consultant1989 — 1991
- University of Chicago Department of Molecular Genetics and Cell Biology (MGCB)Senior Research Technologist1987 — 1989
Skills & more
Biotechnology66Pharmaceutical Industry26Life Sciences15Biopharmaceuticals14Technology Transfer6Strategy37Drug Development7Immunology32Oncology4Drug Discovery7Antibodies2Biochemistry1
+8 more
Business DevelopmentCancerCell BiologyClinical DevelopmentClinical TrialsCommercializationCorporate DevelopmentCross-functional Team LeadershipFrom Clifford's professional profile.
Frequently asked questions
- Who is Clifford J. Stocks?
- Director, Executive Officer at OncoResponse
- Where does Clifford J. Stocks work?
- Clifford J. Stocks is Executive at OncoResponse.
- Where did Clifford J. Stocks go to school?
- Clifford J. Stocks studied at The University of Chicago Booth School of Business (MBA, Statistics; Operations; Leadership); University of Utah (B.S., Biology).
Same school
Also attended The University of Chicago Booth School of Business941
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital
+ 935 more
Also attended University of Utah212
Sid KrommenhoekPartner at AlbumKelly KoVice President of Technology Ventures and Innovation at Flare Capital PartnersTravis HeathAdministrative Partner & CFO at Signal Peak VenturesAidan DaoussisPrincipal at Balerion Space VenturesHelen McBrideOperating Partner at BOLD LongevityCharlotte MageePrincipal at Enable Ventures
+ 206 more
